John H. Chiu, M.D.

Dr. Chiu is the newest cardiologist to join CCMG.  Just prior to joining our practice in 2006, he completed an Advanced Fellowship in Interventional Cardiology at the Cleveland Clinic in Cleveland, OH.  He is a graduate of the Massachusetts Institute of Technology and received his M.D. from Washington University School of Medicine.  Dr. Chiu has additional training, and a particular interest in the diagnosis and treatment of Peripheral Arterial Disease.

CLINICAL EXPERIENCE
2004-2006:

The Cleveland Clinic Foundation Cleveland, OH
Chief Interventional Cardiology Fellow
Interventional Cardiology Fellowship
(coronary, peripheral, and carotid intervention)

2001-2004:

The Cleveland Clinic Foundation Cleveland, OH
Cardiovascular Medicine Fellowship

1998-2001:

Barnes-Jewish Hospital St. Louis, MO
Internal Medicine Residency

EDUCATION

1994-1998:

Washington University School of Medicine St. Louis, MO
M.D. received in May 1998
Ranked in top third of class

1990-1994:

Massachusetts Institute of Technology Cambridge, MA
Bachelor of Science degree received in 1994
Major in Biology with a minor in Economics

CERTIFICATION

Diplomate in Interventional Cardiology, American Board of Internal Medicine, 2005; Certificate valid through 12/31/2015

Diplomate in Cardiovascular Disease, American Board of Internal Medicine, 2004; Certificate valid through 12/31/2014

Diplomate in Internal Medicine, American Board of Internal Medicine, 2001; Certificate valid through 12/31/2011

Diplomate of the Certification Board of Nuclear Cardiology, 2005; Certificate valid through 12/31/2015

Permanent medical licensure granted by State Medical Board of Ohio

Permanent medical licensure granted by the Medical Board of
California

BASIC SCIENCE RESEARCH EXPERIENCE

1994:

Research Assistant, Biology Department, Massachusetts Institute of Technology. Investigation of the ATP-dependent multi-drug resistance pump in Enterococcus
hirae.

1993:

Teaching Assistant for the Introduction to Experimental Biology course, Massachusetts Institute of Technology.

1992:

Research Assistant, Biology Department, Massachusetts Institute of Technology. Work involved the cloning and sequencing of gene fusions in Escherichia coli.

1992:

Research Assistant, The Boston Heart Foundation.
Investigation of the effects of low-density lipoproteins on cell proliferation and metabolism of matrix molecules in Bovine aortic smooth muscle cells and endothelial cells.

1989:

Research Assistant, The Population Council, Rockefeller University, NY, NY. Investigation of the effects of hydrocortisone on Phaseolus aureus root growth and elongation, and localization of hydrocortisone receptor sites.

PUBLICATIONS

Christofferson RD, Duffy B, Chiu JH, Kapadia SR, Whitlow PL. Immediate and long-term outcome after percutaneous coronary intervention for chronic total occlusion in a large, single-center registry. Presented at the 2006 SCAI Scientific Sessions.
[abstract]

Karha J, Chiu JH, Rajagopal V, Henderson MR, Ellis SG, Brener SJ. C-Reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with sirolimus eluting stent. Presented at the 2005 AHA Scientific Sessions. Circulation suppl. [abstract]

Chiu JH, Abdelhadi RH, Chung MK, Gurm HS, Marrouche NF, Saliba WI, Natale A, Martin DO. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary disease and an implantable cardioverter-defibrillator. American Journal
of Cardiology. 2005; 95:490-491.

Chiu JH, Bhatt DL, Ziada KM, Chew DP, Whitlow PL, Lincoff AM, Ellis SG, Topol EJ. Impact of female sex on outcome after percutaneous coronary intervention. American Heart Journal. 2004; 148:998-1002.

Jefferson, BK, Chiu JH, Tuzcu EM, Lincoff AM. Bivalirudin use in primary percutaneous coronary intervention in a patient at high risk for thromboembolic complications. Journal of Invasive Cardiology. 2004; 6(9).

Barman N, Chiu JH, Ellis SG. Transradial Catheterization: The Road Less Traveled. Journal of Invasive Cardiology. 2004; 16:639-640.
Chiu JH, Bhatt DL, Ziada KM, Ellis SG. Impact of gender on outcome following percutaneous coronary intervention. JACC. 2004; 43(5 suppl A):413. [abstract]

Hook MA, Chiu JH, Askari A, Seshadri N, Pearce GL, Sprecher DL. Clustering of novel risk factors correlates with the metabolic syndrome. JACC. 2004; 43(5 suppl A):297. [abstract]

Hook MA, Chiu JH, Seshadri N, Messerli A, Griffin BP, Pearce GL, Sprecher DL. Clustering of novel risk factors correlates with traditional risk burden and coronary artery
disease. Circulation. 2004; 109(6 suppl e):20. [abstract]

Hook MA, Chiu JH, Seshadri N, Messerli A, Hoogwerf BJ, Griffin BP, Pearce GL, Sprecher DL. Association of plasma total homocysteine and the metabolic syndrome in a preventive cardiology clinic. Circulation. 2004; 109(6 suppl e):63. [abstract]

Chiu JH, Topol EJ, Whitlow PL, Hsu AP, Tuzcu EM, Franco I, Moliterno DJ. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. American Journal of Cardiology. 2003; 92:582-583.

Chiu JH, Abdelhadi RH, Natale A, Gurm HS, Chung MK, Marrouche NF, Saliba WI, Rossillo A, Saad EB, Martin DO. Statin therapy reduces the risk of shock from an implantable cardioverter-defibrillator. Circulation. 2003; 108(17 suppl IV):543. [abstract]

Chiu JH, Bhatt DL, Moliterno DJ, Ellis SG. Peripheral arterial disease independently predicts higher mortality rates following percutaneous coronary intervention. Circulation. 2003; 108(17 suppl IV):358. [abstract]

BOOK CHAPTERS

Chiu JH, Bhalla H. Hypertensive Crisis. In: Griffin BP, Topol EJ, eds. Manual of Cardiovascular Medicine, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 2004:486-497.

Chiu JH, Moen EK. Post-myocardial infarction risk stratification and management. In: Griffin BP, Topol EJ, eds. Manual of Cardiovascular Medicine, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 2004:64-73.

Chiu JH, Patel VB. Assessing and managing cardiac risk in noncardiac surgical procedures. In: Griffin BP, Topol EJ, eds. Manual of Cardiovascular Medicine, 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 2004:472-485.

CLINICAL TRIAL EXPERIENCE

Member, Clinical Events Adjudication Committee, Clopidogrel for High Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA). Principal Investigator: Deepak L. Bhatt, MD, 2003-2006.

HONORS AND AWARDS

2002: American College of Cardiology/Henry I. Russek Travel Award
1997: Harrison Scholar, Washington University School of Medicine
1994: Phi Beta Kappa, Massachusetts Institute of Technology
1992: MIT Class of 1989 Scholarship, Massachusetts Institute of Technology
1991 & 1992: John Jay and Eliza Watson Scholarship, Massachusetts Institute of Technology